Top Stock Picks of 2026: Bristol-Myers Squibb
For the final few weeks of the first quarter we're going to highlight one of Schaeffer's top 15 picks for 2026. Today, we have drugmaker Bristol-Myers Squibb Co (NYSE:BMY). To access the entirety of the 2026 report, click here.
The following is our analysis from Dec. 23 for the upcoming year.
If interest rates are lower or stable in 2026, capital reallocates from high-multiple growth names to long-duration, cash generative equities. Pharma stock Bristol-Myers Squibb (BMY) could stand to benefit from this rotation, screening extremely well on free cashflow yield and dividend sustainability.
Thanks to this rotation starting at the end of 2025, BMY has reclaimed its 200-month moving average, as well as a long-term trendline connecting higher highs from 2004-2012.
The shares could test their March 2025 highs of $63, nearly 18% upside from this report. If that peak doesn't cap sustained moves higher, there is as much as a 40% upside towards its former long-term high at $75, which could be attained in the next 12 months.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
NEWMARK GROUP INC <NMRK.O>: KBW CUTS TARGET PRICE TO $16 FROM $17.50
NEWMARK GROUP INC : KBW CUTS TARGET PRICE TO $16 FROM $17.50
VALERO ENERGY CORP <VLO.N>: JEFFERIES CUTS TARGET PRICE TO $394 FROM $401
VALERO ENERGY CORP : JEFFERIES CUTS TARGET PRICE TO $394 FROM $401
Gold prices rise Rs 1,500/10g; silver up Rs 3,100/kg ahead of US economic data, softer yields. Buy, sell or hold?
The Shopify Stock Rally Isn't Done: Chart of the Week -- Barrons.com
By Doug Busch Shopify is no longer a pandemic-era growth story that simply failed to slow down. It is compounding at a pace few software platforms its size still manage. In the second quarter of 2026, sales on its platform rose 32%. That was the fifth straight quarter of growth exceeding 30%. Merchants are also using more of Shopify's own tools, from payments to Shop Pay, and new channels like AI shopping agents are starting to increase demand. The simple bull case is that the stock already commands a huge share of independent online commerce, and that position should become more valuable as more buying moves through its checkout. A rule of market mechanics is that the vast majority of an individual security's gain is driven by its underlying sector. Within technology, software has staged a robust recovery, joining semiconductors to power the broader sector higher. The iShares Expanded Tech-Software Sector ETF has maintained an upward trajectory since its mid-April lows, though the advance from $74 to $112 has been choppy as bulls repeatedly stepped in to defend when necessary. Breadth across large-cap software has expanded significantly, with 24 constituents surging over 20% over the past three months. During that same three-month window, Shopify generated outstanding relative strength, advancing 36%, more than doubling the IGV's 17% gain over the same period. Expect the stock's outperformance to persist as software momentum broadens. Let's examine the daily and monthly charts to outline the technical drivers behind this thesis. Looking at the daily chart, the ratio chart against the IGV shows persistent outperformance extending back to mid-May. The stock is riding an eight-session winning streak, during which price action cleared a double-bottom-with-handle pivot at $151.39. Within this broader base, the stock recorded a bullish golden cross in late August and successfully filled its Sept. 10 price gap, tracing back to its Aug. 4 session, the day before a powerful earnings reaction sent the stock surging 17% hi
Crypto prices
More
